Npc1l1-flox 基因敲除小鼠

1. Liao, Jianwei, Yang, Liyun, Zhou, Luping, Cui, Yimin, Ouyang, Dongsheng. 2022. The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial. In Frontiers in pharmacology, 13, 755469. doi:10.3389/fphar.2022.755469. https://pubmed.ncbi.nlm.nih.gov/35359877/

2. Zhao, Xueyan, Li, Jiawen, Tang, Xiaofang, Song, Lei, Yuan, Jinqing. 2021. Association of NPC1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease. In Human gene therapy, 32, 581-588. doi:10.1089/hum.2020.229. https://pubmed.ncbi.nlm.nih.gov/33167740/

3. Thang, Sang Kim, Chen, Pei-Yi, Gao, Wan-Yun, Pan, Min-Hsiung, Yen, Jui-Hung. 2019. Xanthohumol Suppresses NPC1L1 Gene Expression through Downregulation of HNF-4α and Inhibits Cholesterol Uptake in Caco-2 Cells. In Journal of agricultural and food chemistry, 67, 11119-11128. doi:10.1021/acs.jafc.9b05221. https://pubmed.ncbi.nlm.nih.gov/31525874/